pharmaceutical investing Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences
CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
